Clinical features of anti-chrome antibodies associated with anti-centromere antibodies

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 285-290

  Iwai, T ^b   Muro, Y ^b   Sugimoto, K ^a,b   Matsumoto, Y ^b   Ohashi, M ^b  

^a Osaka Prefecture University   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti centromere antiboides; Anti chromo antibodies; Autoepitope; Chromo domain; Rheumatic diseases

Indexed keywords

AUTOANTIBODY;

ARTICLE; AUTOIMMUNITY; CENTROMERE; CONTROLLED STUDY; DIAGNOSIS; ETIOLOGY; FEMALE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030018086     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-749.x     Document Type: Article

References (39)

1. Moroi Y, Peebles C, Fritzler MJ et al. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980; 77:1627-31.
2. Tan EM, Rodnan GP, Garcia I et al. Diversity of antinuclear antibodies in progressive systemic sclerosis: anticentromere antibody and its relationship to CREST syndrome. Arthritis Rheum 1980; 23:617-25.
3. Fritzler MJ, Kinsella TD, Garbutt E. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 1980; 69:520-6.
4. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31:196-203.
5. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44:93-151.
6. Muro Y, Sugimoto K, Okazaki T et al. The heterogeneity of anticentromere antibodies in immunoblotting analysis. J Rheumatol 1990; 17:1042-7.
7. Earnshaw W, Bordwell B, Marino C et al. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 1986; 77:426-30.
8. Earnshaw WC, Sullivan KF, Machlin PS et al. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol 1987; 104:817-29.
9. Sullivan KF, Glass CA. CENP-B is a highly conserved mammalian centromere protein with homology to the helix-loop-helix family of proteins. Chromosoma 1991; 100:360-70.
10. Saitoh H, Tomkiel J, Cooke CA et al. CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate. Cell 1992; 70:115-25.
11. Sullivan KF, Hechenberger M, Masn K. Human CENP-A contains a histone H3 related histone fold domain that is required for targeting to the centromere. J Cell Biol 1994; 127:581-92.
12. Earnshaw WC, Machlin PS, Bordwell BJ et al. Analysis of anti-centromere autoantibodies using cloned autoantigen CENP-B. Proc Natl Acad Sci USA 1987; 84:4979-83.
13. Muro Y, Masumoto H, Okazaki T et al. Purification of a human centromere antigen (CENP-B) and application of DNA immunoprecipitation to quantitative assay for anti-CENP-B antibodies. J Invest Dermatol 1991; 97:378-80.
14. Sugimoto K, Migita H, Hagishita Y et al. An antigenic determinant on human centromere protein B (CENP-B) available for production of human-specific anticentromere antibodies in mouse. Cell Struct Funct 1992; 17:129-38.
15. Muro Y, Sugimoto K, Himeno M et al. The clinical expression in anticentromere antibody-positive patients is not specified by the epitope recognition of CENP-B antigen. J Dermatol 1992; 19:584-91.
16. Verheijen R, de Jong BAW, Oberye EHH et al. Molecular cloning of a major CENP-B epitope and its use for the detection of anticentromere autoantibodies. Mol Biol Rep 1992; 16:49-59.
17. Guldner HH, Lakomek HJ, Bautz FA. Human anti-centromere sera recognize a 19.5 kDa non-histone chromosomal protein from HeLa cells. Clin Exp Immunol 1984; 58:13-20.
18. Earnshaw WC, Rothfield N. Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma 1985; 91:313-21.
19. McHugh NJ, James IE, Maddison PJ. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease. Clin Exp Immunol 1988; 72:457-64.
20. Soriano E, Whyte J, McHugh NJ. Frequency and clinical associations of anti-chromo antibodies in connective tissue disease. Ann Rheum Dis 1994; 53:666-70.
21. Nicol L, Jeppesen P. Human autoimmune sera recognize a conserved 26 kDa protein associated with mammalian heterochromatin that is homologous to heterochromatin protein 1 of Drosophila. Chromosome Res 1994; 2:245-53.
22. Saunders WS, Chue C, Goebl M et al. Molecular cloning of a human homologue of Dorosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity. J Cell Sci 1993; 104:573-82.
23. Eissenberg JC, James TC, Foster-Hartnett DM et al. Mutation in a heterochromatin-specific chromosomal protein is associated with suppression of position-effect variegation in Drosophila melanogaster. Proc Natl Acad Sci USA 1990; 87:9923-7.
24. Eissenberg JC, Morris GD, Reuter G et al. The heterochromatin-associated protein HP-1 is an essential protein in Drosophila with dosage-dependent effects on position-effect variegation. Genetics 1992; 131:345-52.
25. Paro R, Hogness DS. The polycomb protein shares a homologous domain with a heterochromatin-associated protein of Drosophila. Proc Natl Acad Sci USA 1991; 88:263-7.
26. Singh PB, Miller JR, Pearce J et al. A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants. Nucleic Acid Res 1991; 19:789-94.
27. Epstein H, James TC, Singh PB. Cloning and expression of Drosophila HP1 homologues from a mealybug, Planococcus citri. J Cell Sci 1992; 101:463-74.
28. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erytematosus. Arthritis Rheum 1982; 25:1271-7.
29. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
30. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Eng J Med 1975; 292:344-7.
31. Homma M, Tojo T, Akizuki M et al. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol (Suppl.) 1986; 61:26-27.
32. Kasukawa R, Tojo T, Miyawaki S et al. Preliminary diagnosticcriteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier, 1987: 41-47.
33. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
34. Young RA, Davis RW. Yeast RNA polymerase II genes: isolation with antibody probes. Science 1983; 222:778-82.
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
36. Platero JS, Hartnett T, Eissenberg JC. Functional analysis of the chromo domain of HP1. EMBO J 1995; 14:3977-86.
37. Tan EM, Autoimmunity and apoptosis. J Exp Med 1994; 179:1083-6.
38. Tan EM, Muro Y, Pollard KM. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions. Clin Exp Rheumatol 1994; 12 (Suppl. 11): S27-S31.
39. Powers JA, Eissenberg JC. Overlapping domains of the heterochromatin-associated protein HP1 mediate nuclear localization and heterochromatin binding. J Cell Biol 1993; 120:291-9.